Articles

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
Yale University School of Medicine, New Haven, CT, USA
University of Washington School of Medicine, Seattle, WA, USA
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
Hematology-Oncology Samsung Medical Center, Seoul, South Korea
Hospital del Salvador, Universidad de Chile, Santiago, Chile
Department of Hematology, Hospital Clinic, Barcelona, Spain
Sheba Medical Center, Tel Hashomer, Israel
Stanford University, Stanford, CA, USA
Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
Department of Pathology, Samsung Medical Center, Seoul, South Korea
Hospital del Salvador, Universidad de Chile, Santiago, Chile
Department of Haemato-Oncology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Departamento de Clínica Médica, FCM da Santa Casa de São Paulo, Brazil
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Medical Oncology A, National Cancer Institute, Aviano, Italy
Department of Medicine, University Hospital and School of Medicine, Universidade Federal do Rio de Janeiro, Brazil
Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
Vol. 103 No. 7 (2018): July, 2018 https://doi.org/10.3324/haematol.2017.186577